Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
8.20B | 7.10B | 8.63B | 7.35B | 6.38B | Gross Profit |
854.70M | 811.33M | 1.04B | 884.34M | 843.97M | EBIT |
-154.49M | 378.88M | 684.29M | 503.89M | 544.51M | EBITDA |
252.89M | 672.26M | 923.18M | 740.15M | 795.42M | Net Income Common Stockholders |
-370.39M | 257.57M | 644.52M | 640.55M | 533.08M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.62B | 3.16B | 3.01B | 2.96B | 3.07B | Total Assets |
20.36B | 20.32B | 20.21B | 18.61B | 17.04B | Total Debt |
4.55B | 3.98B | 4.13B | 3.58B | 3.43B | Net Debt |
2.10B | 1.47B | 1.61B | 1.02B | 655.97M | Total Liabilities |
10.02B | 9.33B | 8.99B | 8.04B | 7.36B | Stockholders Equity |
9.78B | 10.39B | 10.59B | 9.93B | 9.07B |
Cash Flow | Free Cash Flow | |||
-365.25M | -171.85M | 37.14M | 109.97M | 153.23M | Operating Cash Flow |
-245.80M | -7.06M | 342.54M | 317.44M | 330.90M | Investing Cash Flow |
239.06M | -276.31M | -772.36M | -265.94M | 1.17B | Financing Cash Flow |
374.51M | -158.74M | 351.63M | -344.84M | -430.96M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $1.83B | 7.10 | 7.44% | 9.35% | -12.74% | -17.17% | |
62 Neutral | $4.13B | 11.17 | 5.46% | 215.76% | 4.12% | -8.54% | |
60 Neutral | HK$665.90M | 22.30 | 4.61% | 6.81% | 1.46% | -22.18% | |
44 Neutral | $5.30B | 15.80 | 0.81% | 6.93% | 17.77% | -58.48% | |
42 Neutral | HK$1.17B | ― | -3.47% | 5.64% | 7.83% | -296.70% | |
32 Underperform | €163.37M | ― | -199.48% | ― | 51.93% | -374.56% |